PainReform Ltd.
PRFX
$2.44
$0.125.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -16.37% | -24.38% | -28.63% | -22.80% | -20.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.10% | 87.10% | 77.90% | 32.46% | 8.06% |
| Operating Income | -53.10% | -87.10% | -77.90% | -32.46% | -8.06% |
| Income Before Tax | -56.17% | -144.18% | -81.09% | -33.38% | -6.30% |
| Income Tax Expenses | 0.00% | 33.33% | -11.11% | -11.11% | -11.11% |
| Earnings from Continuing Operations | -56.12% | -144.05% | -81.00% | -33.34% | -6.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.12% | -144.05% | -81.00% | -33.34% | -6.28% |
| EBIT | -53.10% | -87.10% | -77.90% | -32.46% | -8.06% |
| EBITDA | -53.17% | -87.21% | -78.07% | -32.49% | -8.08% |
| EPS Basic | 32.34% | -13.47% | 11.98% | 9.51% | 11.33% |
| Normalized Basic EPS | 32.30% | -13.53% | 11.96% | 9.48% | 11.30% |
| EPS Diluted | 32.38% | -13.39% | 12.04% | 9.49% | 11.31% |
| Normalized Diluted EPS | 32.30% | -13.53% | 11.96% | 9.48% | 11.30% |
| Average Basic Shares Outstanding | 1,354.91% | 793.12% | 96.74% | 41.13% | 20.84% |
| Average Diluted Shares Outstanding | 1,354.91% | 793.12% | 96.74% | 41.13% | 20.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |